eripheral arterial disease (PAD) is a clinical manifestation of the atherosclerotic process, which is associated with cardiovascular disease (CVD) and increased CVD risk. [1][2][3] Noninvasive testing reveals that up to 20% of elderly individuals have PAD 4-7 and because only a small percentage of these individuals are symptomatic, the condition is poorly recognized in primary care practice. 8,9 Several cohort studies have shown that a low ankle -brachial index (ABI) is a risk factor of fatal and nonfatal coronary heart disease (CHD) and all-cause mortality among people with and without existing clinical coronary artery disease, and among people with existing peripheral vascular disease. [10][11][12] Low ABI is also associated with the incidence of stroke in the elderly. 2 Diabetes mellitus (DM), a major chronic disease, is able to accelerate atherosclerosis and numerous studies have identified it as a key risk factor for PAD. 13-17 Several cohort and randomly selected studies have revealed that CVD event rates in patients with PAD and DM are higher than in their nondiabetic counterparts. 18,19 The adjusted risk of death for PAD patients with DM is 2-fold higher than in patients without DM. 20 A recent prospective study reported Circulation Journal Vol. 71, March 2007 that in diabetic patients with low ABI (<0.9), CVD and allcause mortalities were 31.7 and 70.5 per 1000 personyears, respectively. 21 Except for 1 study that reported 16.7% PAD prevalence in Chinese patients with type 2 DM, this issue has not been researched extensively. 22 Thus, the purposes of this study were to evaluate the risk factors of PAD and to elucidate the relationship between ABI and mortality from all-cause and CVD in diabetic Chinese patients.
Methods
Study SubjectsSubjects were recruited from the endocrinology or cardiology in-patient clinic at 8 university hospitals in Beijing and Shanghai from July to November 2004. Participants were diagnosed as diabetic if they had a fasting plasma glucose (FPG) ≥7 mmol/L, reported use of hypoglycemic medication, or had DM at the baseline examination. The inclusion criteria were age older than or equal to 35 years, and FPG ≥7 mmol/L or 2hPG ≥11.1, or reported having DM at the baseline examination. The exclusion criteria were severe heart failure or renal failure and patients with an ABI >1.4. There were 1,706 participants in the DM cohort, 59 of whom had missing follow-up data. Therefore, the study sample comprised 1,647 valid participants (815 men, 832 women; mean age 67.8±10.6 years) who were followed up from November 2004 to January 2006. This study was approved by the ethics committee of Tongji University and informed consent was given by the